Page 55 - Read Online

Friedman et al. Plast Aesthet Res 2023;10:23 https://dx.doi.org/10.20517/2347-9264.2022.100 Page 13 of 15

2013;86:498-503. DOI
45. Cariati M, Bains SK, Grootendorst MR, et al. Adjuvant taxanes and the development of breast cancer-related arm lymphoedema. Br J
Surg 2015;102:1071-8. DOI
46. Kilbreath SL, Refshauge KM, Beith JM, et al. Risk factors for lymphoedema in women with breast cancer: a large prospective cohort.
Breast 2016;28:29-36. DOI
47. Swaroop MN, Ferguson CM, Horick NK, et al. Impact of adjuvant taxane-based chemotherapy on development of breast cancer-
related lymphedema: results from a large prospective cohort. Breast Cancer Res Treat 2015;151:393-403. DOI PubMed PMC
48. Johnson AR, Granoff MD, Lee BT, Padera TP, Bouta EM, Singhal D. The impact of taxane-based chemotherapy on the lymphatic
system. Ann Plast Surg 2019;82:S173-8. DOI PubMed
49. Specht MC, Miller CL, Skolny MN, et al. Residual lymph node disease after neoadjuvant chemotherapy predicts an increased risk of
lymphedema in node-positive breast cancer patients. Ann Surg Oncol 2013;20:2835-41. DOI
50. Jung SY, Shin KH, Kim M, et al. Treatment factors affecting breast cancer-related lymphedema after systemic chemotherapy and
radiotherapy in stage II/III breast cancer patients. Breast Cancer Res Treat 2014;148:91-8. DOI
51. Wilke LG, McCall LM, Posther KE, et al. Surgical complications associated with sentinel lymph node biopsy: results from a
prospective international cooperative group trial. Ann Surg Oncol 2006;13:491-500. DOI
52. Kim M, Park IH, Lee KS, et al. Breast cancer-related lymphedema after neoadjuvant chemotherapy. Cancer Res Treat 2015;47:416-
23. DOI
53. Hayes SC, Janda M, Cornish B, Battistutta D, Newman B. Lymphedema after breast cancer: incidence, risk factors, and effect on
upper body function. J Clin Oncol 2008;26:3536-42. DOI PubMed
54. Shang T, Liang J, Kapron CM, Liu J. Pathophysiology of aged lymphatic vessels. Aging 2019;11:6602-13. DOI PubMed PMC
55. Kwan ML, Yao S, Lee VS, et al. Race/ethnicity, genetic ancestry, and breast cancer-related lymphedema in the pathways study.
Breast Cancer Res Treat 2016;159:119-29. DOI PubMed PMC
56. Meeske KA, Sullivan-Halley J, Smith AW, et al. Risk factors for arm lymphedema following breast cancer diagnosis in Black women
and White women. Breast Cancer Res Treat 2009;113:383-91. DOI
57. Guliyeva G, Huayllani MT, Boczar D, Avila FR, Lu X, Forte AJ. Age as a risk factor for breast cancer-related lymphedema: a
systematic review. J Cancer Surviv 2023;17:246-53. DOI PubMed
58. Zou L, Liu FH, Shen PP, et al. The incidence and risk factors of related lymphedema for breast cancer survivors post-operation: a 2-
year follow-up prospective cohort study. Breast Cancer 2018;25:309-14. DOI
59. Byun HK, Kim JS, Chang JS, et al. Validation of a nomogram for predicting the risk of lymphedema following contemporary
treatment for breast cancer: a large multi-institutional study (KROG 20-05). Breast Cancer Res Treat 2022;192:553-61. DOI
60. Siotos C, Hassanein AH, Bello RJ, et al. Delayed breast reconstruction on patients with upper extremity lymphedema: a systematic
review of the literature and pooled analysis. Ann Plast Surg 2018;81:730-5. DOI
61. Basta MN, Fischer JP, Kanchwala SK, et al. A propensity-matched analysis of the influence of breast reconstruction on subsequent
development of lymphedema. Plast Reconstr Surg 2015;136:134e-43e. DOI
62. McLaughlin SA, Brunelle CL, Taghian A. Breast Cancer-related lymphedema: risk factors, screening, management, and the impact of
locoregional treatment. J Clin Oncol 2020;38:2341-50. DOI PubMed PMC
63. Yamada Y. The studies on lymphatic venous anastomosis in lvmphedema. Available from: https://scholar.google.com/scholar?hl=zh-
CN&as_sdt=0%2C5&q=Yamada+Y.+The+Studies+on+Lymphatic+Venous+Anastomosis+in+Lvmphedema.+Nagoya+J+Med+Sci.+
1969%3B32%3A1-21.&btnG [Last accessed on 22 May 2023]
64. Boccardo F, Casabona F, De Cian F, et al. Lymphedema microsurgical preventive healing approach: a new technique for primary
prevention of arm lymphedema after mastectomy. Ann Surg Oncol 2009;16:703-8. DOI
65. Boccardo F, Casabona F, De Cian F, et al. Lymphatic microsurgical preventing healing approach (LYMPHA) for primary surgical
prevention of breast cancer-related lymphedema: over 4 years follow-up. Microsurgery 2014;34:421-4. DOI
66. Johnson AR, Singhal D. Immediate lymphatic reconstruction. J Surg Oncol 2018;118:750-7. DOI PubMed
67. Coriddi M, Mehrara B, Skoracki R, Singhal D, Dayan JH. Immediate lymphatic reconstruction: technical points and literature review.
Plast Reconstr Surg Glob Open 2021;9:e3431. DOI PubMed PMC
68. Wiser I, Weinstein A, Kenworthy E, Mehrara B, Dayan J. Standardizing upper extremity indocyanine green lymphography in a
lymphedema outpatient setting. Plast Reconstr Surg Glob Open 2020;8:45. DOI
69. Spiguel L, Shaw C, Katz A, et al. Fluorescein isothiocyanate: a novel application for lymphatic surgery. Ann Plast Surg
2017;78:S296-8. DOI
70. Russell PS, Velivolu R, Maldonado Zimbrón VE, et al. Fluorescent tracers for in vivo imaging of lymphatic targets. Front Pharmacol
2022;13:952581. DOI PubMed PMC
71. Abdallah M, Müllertz OO, Styles IK, et al. Lymphatic targeting by albumin-hitchhiking: Applications and optimisation. J Control
Release 2020;327:117-28. DOI
72. Trevaskis NL, Kaminskas LM, Porter CJ. From sewer to saviour - targeting the lymphatic system to promote drug exposure and
activity. Nat Rev Drug Discov 2015;14:781-803. DOI PubMed
73. Mele A, Fan B, Pardo J, et al. Axillary lymph node dissection in the era of immediate lymphatic reconstruction: Considerations for
the breast surgeon. J Surg Oncol 2021;123:842-5. DOI
74. Visconti G, Yamamoto T, Hayashi N, Hayashi A. Ultrasound-assisted lymphaticovenular anastomosis for the treatment of peripheral